James R. Empfield Xenon Pharmaceuticals Inc. (XENE) insider trading activity
James R. Empfield is EVP, Drug Discovery of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 10,000 shares of XENE, which is worth approximately $416,800. The most recent transaction as insider was on Aug 12, 2022, when has been sold 7,257 shares (Common Shares) at a price of $38.02 per share, resulting in proceeds of $275,911. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
10K
0%
3M change
0%
12M change
Total Value Held
$416,800
JAMES R. EMPFIELD Transaction History
JRE
James R. Empfield
EVP, Drug Discovery
Burnaby, A1